Investigations

  • Girard Sharp is investigating potential violations of state and federal law by Conagra in connection with its October 2018 acquisition of Pinnacle Foods. The investigation centers on potential misrepresentations and omissions by Conagra concerning the strength of several of Pinnacle’s brands. The transaction was valued at approximately $10.9 billion.

  • Girard Sharp is investigating potential violations of state and federal law by WeWork and its prime investor, Japan’s SoftBank, following the recent buyout of ousted CEO Adam Neumann, and the cancellation of WeWork’s IPO. According to reports, the failed IPO caused WeWork to sustain a significant drop in value.

Pending Cases

  • Girard Sharp has filed a class action complaint charging JUUL with unlawfully marketing dangerous e-cigarettes and manipulating nicotine delivery to maximize addiction, causing a public health crisis and harming tens of thousands of minors and adults across the country.

  • Girard Sharp has filed a class action lawsuit following reports that certain Allergan BIOCELL© breast implants may cause anaplastic large cell lymphoma (“BIA-ALCL”), a cancer of the immune system. Access a copy of the complaint here.

    Allergan implemented a worldwide recall of BIOCELL© implants in July 2019.

Results

  • $104.75 million settlement reached on the eve of trial on behalf of purchasers of the prescription drug Lidoderm.

  • Jay Peak EB-5 Fraud

    $150 million partial settlement recovered for investors in various Jay Peak EB-5 Immigrant Investor Program project offerings, whose funds were diverted for unauthorized uses.

Main Menu